Home 
How Blumble Works 
Search Algorithm 
Your Privacy 
About 
Facebook
Twitter
Blog
86
100
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. An…
- Safe
- United States
- Encrypted
- 23 yrs old
- 13 Site Rank
- Report Card
77
100
Pfizer completes its acquisition of Seagen, a leader in Antibody-Drug Conjugate (ADC) technology, for $43 billion. The deal expands Pfizer's Oncology …
- Safe
- United States
- Encrypted
- 32 yrs old
- 4,987 Site Rank
- Report Card
77
100
Pfizer and Seagen have merged to form a world-leader in antibody-drug conjugates (ADCs) and other cancer treatments. Learn about their products, vision, and achievements in …
- Safe
- United States
- Encrypted
- 32 yrs old
- 4,987 Site Rank
- Report Card
77
100
Pfizer and Seagen have now received all required regulatory approvals to complete the acquisition. Pfizer expects to close the acquisition of Seagen on December …
- Safe
- United States
- Encrypted
- 32 yrs old
- 4,987 Site Rank
- Report Card
89
100
Pfizer has completed its acquisition of Seagen, a global biotech company that develops and commercializes cancer medicines, for $43 billion. The deal …
- Safe
- United States
- Encrypted
- 29 yrs old
- 19 Site Rank
- Report Card
WEBSITE REPORT CARD
-
![]()
Norton safe Web
-
McAfee Web Advisor
-
Site is
-
Hosted in
-
-
Traffic rank:
-
Site age:
-
Site Owner information
Norton safe Web